Hamel Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,815
Closed -$235K 81
2023
Q1
$235K Hold
1,815
0.08% 77
2022
Q4
$247K Hold
1,815
0.09% 76
2022
Q3
$220K Hold
1,815
0.09% 79
2022
Q2
$233K Hold
1,815
0.09% 77
2022
Q1
$249K Hold
1,815
0.09% 73
2021
Q4
$256K Hold
1,815
0.09% 72
2021
Q3
$231K Buy
1,815
+75
+4% +$9.91K 0.09% 68
2021
Q2
$219K Buy
+1,740
New +$213K 0.08% 66

Other funds holding XLV

Hamel Associates's XLV Position: Q2 2023 in Review

Hamel Associates sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2023, closing a stake of 1,815 shares — an estimated $235K sold.

Hamel Associates first reported a position in XLV in Q2 2021 and held it in 8 quarters. The position peaked at $256K in Q4 2021. 1,542 funds tracked by Wall St. Rank hold XLV as of Q2 2023.

  • Hamel Associates reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2023 after selling out during the quarter.
  • Hamel Associates sold 1,815 State Street Health Care Select Sector SPDR ETF shares in Q2 2023, an estimated $235K.
  • Hamel Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2021 and held it in 8 quarters.
  • Hamel Associates's State Street Health Care Select Sector SPDR ETF position peaked at $256K in Q4 2021.
  • 1,542 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2023.

Based on Hamel Associates's 13F filing for Q2 2023, filed 8 Aug 2023.